Jane Lowe Meisel, MD

Assistant Professor, Hematology & Medical Oncology

Emory University School of Medicine

Assistant Professor, Gynecology & Obstetrics

Emory University School of Medicine

Office: Winship Cancer Institute of Emory University

Phone: (404) 778-5994

For all patient inquiries or appointment requests, please dial (404) 778-1900. Fax patient records to (404) 778-2177.


Jane Meisel, MD, joined the Department of Hematology and Medical Oncology of Emory University as an assistant professor in January 2015. Dr. Meisel's clinical interests are in women's health and in cancers that affect women, including breast, cervical, endometrial, and ovarian cancers.

A native of Atlanta, Dr. Meisel graduated magna cum laude from Harvard College in 2004 with a degree in the History of Science, and earned her medical degree in 2008 from Harvard Medical School. She completed her residency in internal medicine at Brigham and Women's Hospital in Boston, MA in 2011; during that time, she also conducted research on breast cancer at the Dana-Farber Cancer Institute. She completed her fellowship in medical oncology at Memorial Sloan Kettering Cancer Center in New York, NY, and served as Chief Fellow there from 2013 to 2014.

Dr. Meisel is a member of the Eastern Cooperative Oncology Group and serves on the Development Therapeutics Committee at NRG Oncology. She also serves as leader of the Professional Development Committee Women in Oncology Work Group and as a member of the Cancer Education Committee at American Society of Clinical Oncology.

Full Clinical Bio >>


Dr. Meisel has presented her research on breast cancer and gynecologic malignancies at national meetings and has published her work in peer-reviewed journals. Her research is focused on the development of new therapeutic options for women with gynecologic and breast cancers, and on improving quality of life for these patients. Her work has also focused on gaining a better understanding of the genetic mutations that confer susceptibility to breast and ovarian cancer, such as the BRCA1 and BRCA2 genes.


Clinical Trials

View clinical trials at Winship Cancer Institute